Fintel reports that on February 10, 2025, Canaccord Genuity downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) ...

Investment analysts at Ventum Cap Mkts dropped their FY2025 earnings per share (EPS) estimates for shares of Canaccord ...

In a report released on February 7, Alex Brooks from Canaccord Genuity reiterated a Buy rating on Invinity Energy Systems (IES – Research ...

In a report released today, Owen Humphries from Canaccord Genuity maintained a Buy rating on Temple & Webster Group Ltd (TPLWF – Research ...

Illumina (NASDAQ:ILMN – Free Report) had its price objective cut by Canaccord Genuity Group from $145.00 to $135.00 in a report published on Friday,Benzinga reports. They currently have a hold rating ...

ASX small-cap shares are slightly outperforming the broader market in 2025. The post Experts reveal 4 ASX small-cap shares to ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

Sanofi S.A. Part Cert-1.97% €8.03M ...